Importantly, using NADPH oxidase‐deficient neutrophils isolated from patients (n = 3) with chronic granulomatous disease (CGD), we observed a reduction in candidalysin‐triggered NLS (30–40%) that was comparable to the effect of the ROS inhibitors (Fig 4G and H). Here, FMO5 is linked to chronic granulomatous disease.